EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification

Åsa Johansson iD, Ole A Andreassen, Søren Brunak iD, Paul W Franks iD, Harald Hedman, Ruth J F Loos iD, Benjamin Meder, Erik Melén, Craig E Wheelock, Bo Jacobsson

Journal of Internal Medicine · 2023-10 · 294 (4) · 378-396

DOI: 10.1111/joim.13640 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 24.04.2023. Verfasst von Åsa Johansson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Precision Medicine, Mental Disorders. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, Vetenskapsrådet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complex diseases are caused by a combination of genetic, lifestyle, and environmental factors and comprise common noncommunicable diseases, including allergies, cardiovascular disease, and psychiatric and metabolic disorders. More than 25% of Europeans suffer from a complex disease, and together these diseases account for 70% of all deaths. The use of genomic, molecular, or imaging data to develop accurate diagnostic tools for treatment recommendations and preventive strategies, and for disease prognosis and prediction, is an important step toward precision medicine. However, for complex diseases, precision medicine is associated with several challenges. There is a significant heterogeneity between patients of a specific disease—both with regards to symptoms and underlying causal mechanisms—and the number of underlying genetic and nongenetic risk factors is often high. Here, we summarize precision medicine approaches for complex diseases and highlight the current breakthroughs as well as the challenges. We conclude that genomic‐based precision medicine has been used mainly for patients with highly penetrant monogenic disease forms, such as cardiomyopathies. However, for most complex diseases—including psychiatric disorders and allergies—available polygenic risk scores are more probabilistic than deterministic and have not yet been validated for clinical utility. However, subclassifying patients of a specific disease into discrete homogenous subtypes based on molecular or phenotypic data is a promising strategy for improving diagnosis, prediction, treatment, prevention, and prognosis. The availability of high‐throughput molecular technologies, together with large collections of health data and novel data‐driven approaches, offers promise toward improved individual health through precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineMental DisordersHumansGenomicsRisk Factors

Stichwörter der Autor:innen

GWAScomplex diseasesgenetic variationsgenomic medicinemolecular profilingmulti omicspolygenic risk score (PRS)precision medicine

Autor:innen und Institutionen

  • Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • KG Jebsen Centre for Neurodevelopment Research, University of Oslo, Oslo, Norway.
  • Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rigshospitalet, Blegdamsvej 9, Copenhagen University Hospital, Copenhagen, Denmark.
  • Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Lund, Sweden.

ORCID-Profile: Åsa Johansson, Søren Brunak, Paul W Franks, Ruth J F Loos

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • Vetenskapsrådet
  • Cancerfonden
  • Norges Forskningsråd
  • Novo Nordisk Fonden
  • National Institutes of Health
  • Klaus Tschira Stiftung

Zitieren

APA

Johansson, Å., Andreassen, O. A., Brunak, S., Franks, P. W., Hedman, H., Loos, R. J. F., Meder, B., Melén, E., Wheelock, C. E., & Jacobsson, B. (2023). Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification. Journal of Internal Medicine, 294(4), 378-396. https://doi.org/10.1111/joim.13640

Vancouver

Johansson Å, Andreassen OA, Brunak S, Franks PW, Hedman H, Loos RJF, et al. Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification. Journal of Internal Medicine. 2023;294(4):378-396. doi:10.1111/joim.13640

BibTeX
@article{Johansson2023,
  author = {Johansson, Åsa and Andreassen, Ole A and Brunak, Søren and Franks, Paul W and Hedman, Harald and Loos, Ruth J F and Meder, Benjamin and Melén, Erik and Wheelock, Craig E and Jacobsson, Bo},
  title = {Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification},
  journal = {Journal of Internal Medicine},
  year = {2023},
  volume = {294},
  number = {4},
  pages = {378--396},
  doi = {10.1111/joim.13640}
}
Kostenlos starten →